Interim Chairman of the Board, CFA, and former Assistant United States Surgeon General and Rear Admiral, United States Public Health Service (Retired)
Until his retirement, Dr. Roscoe M. Moore, Jr. served with the United States Department of Health and Human Services (HHS) and was for the last twelve years of his career the principal person responsible for global development support within the Office of the Secretary, HHS, with primary emphasis on Continental Africa and other less developed countries of the world. He was the principal liaison person between the HHS and Ministries of Health in Africa with regard to the development of infrastructure and technical support for the delivery of preventive and curative health needs for the continent.
Dr. Moore received his Bachelor of Science and Doctor of Veterinary Medicine degrees from Tuskegee Institute; his Master of Public Health degree in Epidemiology from the University of Michigan; and his Doctor of Philosophy degree in Epidemiology from the Johns Hopkins University. He was awarded the Doctor of Science degree (Honoris Causa) in recognition of his distinguished public health career by Tuskegee University.
Dr. Moore was a career officer within the Commissioned Corps of the United States Public Health Service (USPHS) entering with the U.S. National Institutes of Health (NIH) and rising to the rank of Assistant United States Surgeon General (Rear Admiral, USPHS) within the Immediate Office of the Secretary, HHS. He was selected as Chief Veterinary Medical Officer, USPHS, by Surgeon General C. Everett Koop.
Dr. Moore served as an Epidemic Intelligence Service Officer with the U.S. Centers for Disease Control and Prevention (CDC). He was with the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA), before becoming Senior Epidemiologist within the National Institute for Occupational Safety and Health, CDC. He served as the Chief Epidemiologist with the Center for Devices and Radiological Health, FDA. He directed the Epidemiology and Biostatistics Program and was an Assistant Professor of Oncology within the Howard University College of Medicine Cancer Center.
Dr. Moore is the Founder and President of PH RockWood Corporation which is focused on the prevention, treatment and control of infectious diseases worldwide. He is a Senior Fellow of the Potomac Institute for Policy Studies. Dr. Moore is a Private Investor in Immunomic Therapeutics Incorporated, a DNA vaccine company. He serves on the Board of Directors for the U.S. subsidiary of Holista CollTech Limited, a publicly traded biotechnology company on the Australian Stock Exchange. Dr. Moore serves as Chief Medical Director of PhytaGenesis LLC, which has submitted Applications for cultivation, processing, and dispensing Medical Cannabis in the State of Maryland. He and others have been awarded a U.S. Patent for the topical use of Cannabis species extracts as a treatment modality for humans and animals. Dr. Moore serves on the Board of Directors for Global Medical REIT LLC, a publicly traded medical real estate investment trust company. He serves on the Board of Directors for Biodefense Gamma LLC which specializes in purified gamma globulin therapy for a number of infectious diseases.
Dr. Moore serves on the Board of Directors for the Safe Blood for China Foundation. He serves on the Board of Directors for Constituency for Africa, and is its Interim Chairman. Dr. Moore is a Senior Advisor to PeerSat Corporation, www.peersat.com.
The Ebola epidemic last year in West Africa exposed large and fundamental healthcare inefficiencies on the African continent, which constrained the development of a suitable and timely response to the outbreak. These deficits included: inadequate numbers of qualified health workers, poor healthcare and social services infrastructure, deficient logistics, slow surveillance and health information systems, weak […]